Executive Summary
- Oklo reported a Q1 net deficit of $33.1 million ($0.19 per share), significantly exceeding last year’s $9.8 million shortfall, while generating no revenue.
- Last week, the Nuclear Regulatory Commission greenlit the Principal Design Criteria for the company’s Aurora powerhouse facility.
- Company leadership under CEO Jacob DeWitte maintains that commercial launch remains scheduled for 2028 or sooner.
- The firm closed Q1 holding $1.59 billion in cash reserves plus $614.5 million in marketable debt instruments, accounting for approximately 82% of total asset value.
- Following quarterly earnings, H.C. Wainwright maintained its Buy recommendation with a $90 price objective for the shares.
Shares of Oklo climbed 0.6% during Wednesday’s premarket session following the nuclear technology firm’s first-quarter financial disclosure and announcement of significant regulatory progress — despite expanding financial losses.
The enterprise recorded a Q1 net deficit of $33.1 million, translating to $0.19 per share. This marks a substantial increase from the year-ago period’s $9.8 million shortfall, equivalent to $0.07 per share. Wall Street consensus had anticipated a $0.20 per share loss, meaning the actual figure narrowly surpassed projections.
Oklo currently generates zero revenue. The firm remains in its pre-commercial development phase, rendering conventional valuation methodologies largely inapplicable.
Capital expenditures for infrastructure and equipment reached $32.8 million throughout the quarter — exceeding the $29.8 million Wall Street forecast. Operating costs totaled $51.5 million, reflecting a roughly 10% sequential decline from the preceding quarter’s $57.1 million.
The company concluded Q1 maintaining $1.59 billion in liquid cash holdings alongside $614.5 million positioned in marketable debt instruments. Combined, these reserves comprise approximately 82% of aggregate assets.
Shares had declined 5.8% in the prior trading session before Wednesday’s premarket recovery.
Aurora Powerhouse Receives Critical NRC Design Authorization
The significant regulatory development: last week, the Nuclear Regulatory Commission granted approval for the Principal Design Criteria governing Oklo’s Aurora powerhouse installation at Idaho National Laboratory.
This framework essentially establishes the core safety protocols and performance standards for the facility. While representing substantial progress toward licensing, complete commercial authorization remains outstanding.
CEO Jacob DeWitte has repeatedly communicated to Barron’s that operational commencement remains targeted for 2028 at the very latest.
Commercial Revenue Channels Beginning to Materialize
As Aurora advances through regulatory procedures, Oklo is developing alternative revenue streams.
The company’s Atomic Alchemy division obtained licensing authorization earlier this calendar year enabling sales from its radiochemistry facility in Idaho. During Tuesday’s announcement, Oklo indicated its inaugural isotope client was “in progress.”
The organization has simultaneously cultivated legitimacy through prominent strategic alliances. Last month, Oklo leveraged Nvidia’s AI infrastructure capabilities to enhance nuclear fuel modeling and computational simulations alongside Los Alamos National Laboratory.
Meta Platforms ranks among Oklo’s established clientele, bolstering the company’s credibility within investment communities.
Since its May 2024 public market debut, Oklo has traded predominantly on future expectations. The stock skyrocketed 238% throughout 2025 while the S&P 500 advanced 16%. This year has proven more subdued — Oklo has appreciated merely 2.6% in 2026 compared with the S&P 500’s 8.1% increase.
The enterprise currently commands a $12.81 billion market capitalization despite producing zero revenue — a valuation certain analysts have characterized as potentially inflated.
H.C. Wainwright preserved its Buy designation and $90 price objective for the shares following the Q1 financial release.


